Safety Success in Hadassah AMD Stem Cell Trial to be Presented at International Conference
Data from the first patient cohort of the Phase I/IIa Hadassah Medical Organization clinical trial with the stem cell product, OpRegen®, aimed at slowing the progression of the advanced form…